SAN DIEGO--(BUSINESS WIRE)--Jul. 16, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps available in the
United States, plans to release its second quarter 2018 results after
the financial markets close on Monday, July 30, 2018. The Company will
hold a conference call and simultaneous webcast on the same day at
4:30pm Eastern Time (1:30pm Pacific Time), to discuss its second quarter
2018 financial and operating results.
Conference Call/Webcast Details:
July 30, 2018
Time:4:30pm Eastern Time (1:30pm Pacific
Toll Free Dial-In Number: (855) 427-4396
Dial-In Number: (484) 756-4261
Conference ID: 7975966
An archive of the webcast will be available for 30 days following the
event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump with Basal-IQ™ technology. The t:slim X2 Pump is
capable of remote feature updates using a personal computer and is the
only automated insulin delivery device approved for children as young as
6 years old. Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark, and t:slim X2 and
Basal-IQ are trademarks of Tandem Diabetes Care, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180716005594/en/
Source: Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc.
Susan Morrison, 858-366-6900 x7005